Alveolar macrophage transcriptional programs are associated with outcomes in acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 200, Issue 6, 2019, Pages 732-741

  Morrell, Eric D ^a   Bhatraju, Pavan K ^a   Mikacenic, Carmen R ^a   Radella, Frank ^a   Manicone, Anne M ^a,b   Stapleton, Renee D ^c   Gharib, Sina A ^a,b   Wurfel, Mark M ^a,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Acute respiratory distress syndrome; Adult; Macrophage; Transcriptome

Indexed keywords

ANGIOPOIETIN 1; CD163 ANTIGEN; CD71 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT5 PROTEIN; TRANSCRIPTOME; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; JAK-STAT SIGNALING; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLUS MACROPHAGE; MALE; MIDDLE AGED; MORTALITY; NEUTROPHIL; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; TIME SERIES ANALYSIS; TRANSCRIPTION INITIATION; AGED; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; INFLAMMATION; TIME FACTOR;

ADULT; AGED; FEMALE; HUMANS; INFLAMMATION; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 85072200209     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201807-1381OC     Document Type: Article

References (44)

1. Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errázuriz P, et al. Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 2013;1:395–401.
2. Aggarwal NR, King LS, D’Alessio FR. Diverse macrophage populations mediate acute lung inflammation and resolution. Am J Physiol Lung Cell Mol Physiol 2014;306:L709–L725.
3. Thompson BT, Chambers RC, Liu KD. Acute respiratory distress syndrome. N Engl J Med 2017;377:562–572.
4. Rosseau S, Hammerl P, Maus U, Walmrath HD, Schütte H, Grimminger F, et al. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2000;279:L25–L35.
5. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 1993;341: 643–647.
6. Jacobs RF, Tabor DR, Burks AW, Campbell GD. Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome. Am Rev Respir Dis 1989;140: 1686–1692.
7. Morrell ED, Radella F II, Manicone AM, Mikacenic C, Stapleton RD, Gharib SA, et al. Peripheral and alveolar cell transcriptional programs are distinct in acute respiratory distress syndrome. Am J Respir Crit Care Med 2018;197:528–532.
8. Morrell ED, Gharib SA, Radella F, Stapleton RD, Wurfel MM. An early M1-like transcriptional program in alveolar macrophages is associated with good outcomes in acute respiratory distress syndrome [abstract]. Am J Respir Crit Care Med 2017;195:A5224.
9. Stapleton RD, Martin TR, Weiss NS, Crowley JJ, Gundel SJ, Nathens AB, et al. A phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injury. Crit Care Med 2011; 39:1655–1662.
10. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545–15550.
11. Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst 2015;1:417–425.
12. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 2014;40: 274–288.
13. Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinformatics 2006;7:191.
14. Ernst J, Nau GJ, Bar-Joseph Z. Clustering short time series gene expression data. Bioinformatics 2005;21(Suppl 1):i159–i168.
15. Wang J, Vasaikar S, Shi Z, Greer M, Zhang B. WebGestalt 2017: a more comprehensive, powerful, flexible and interactive gene set enrichment analysis toolkit. Nucleic Acids Res 2017;45: W130–W137.
16. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al.; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526–2533.
17. Yu YRA, Hotten DF, Malakhau Y, Volker E, Ghio AJ, Noble PW, et al. Flow cytometric analysis of myeloid cells in human blood, bronchoalveolar lavage, and lung tissues. Am J Respir Cell Mol Biol 2016;54:13–24.
18. Morrell ED, Wiedeman A, Long SA, Gharib SA, West TE, Skerrett SJ, et al. Cytometry TOF identifies alveolar macrophage subtypes in acute respiratory distress syndrome. JCI Insight 2018;3:99281.
19. Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, et al. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol 2013;6:256–266.
20. Liao Z, Dong J, Wu W, Yang T, Wang T, Guo L, et al. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARg/NF-kB pathway. Respir Res 2012;13:110.
21. 4. J Immunol 2015;195: 875–881.
22. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature 2009;461:218–223.
23. Calfee CS, Janz DR, Bernard GR, May AK, Kangelaris KN, Matthay MA, et al.; NIH NHLBI ARDS Network. Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 2015;147:1539–1548.
24. Luo L, Shaver CM, Zhao Z, Koyama T, Calfee CS, Bastarache JA, et al. Clinical predictors of hospital mortality differ between direct and indirect ARDS. Chest 2017;151:755–763.
25. Johnston LK, Rims CR, Gill SE, McGuire JK, Manicone AM. Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury. Am J Respir Cell Mol Biol 2012;47: 417–426.
26. Mould KJ, Barthel L, Mohning MP, Thomas SM, McCubbrey AL, Danhorn T, et al. Cell origin dictates programming of resident versus recruited macrophages during acute lung injury. Am J Respir Cell Mol Biol 2017;57:294–306.
27. Srivastava M, Jung S, Wilhelm J, Fink L, Bühling F, Welte T, et al. The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles. J Immunol 2005;175: 1884–1893.
28. D’Alessio FR, Craig JM, Singer BD, Files DC, Mock JR, Garibaldi BT, et al. Enhanced resolution of experimental ARDS through IL-4mediated lung macrophage reprogramming. Am J Physiol Lung Cell Mol Physiol 2016;310:L733–L746.
29. Long ME, Eddy WE, Gong KQ, Lovelace-Macon LL, McMahan RS, Charron J, et al. MEK1/2 inhibition promotes macrophage reparative properties. J Immunol 2017;198:862–872.
30. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep 2014;6:13.
31. Tuomisto TT, Lumivuori H, Kansanen E, Häkkinen S-K, Turunen MP, van Thienen JV, et al. Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2. Cardiovasc Res 2008;78: 175–184.
32. Paine R III, Standiford TJ, Dechert RE, Moss M, Martin GS, Rosenberg AL, et al. A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury. Crit Care Med 2012;40:90–97.
33. McAuley DF, Laffey JG, O’Kane CM, Perkins GD, Mullan B, Trinder TJ, et al.; HARP-2 Investigators; Irish Critical Care Trials Group. Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014;371:1695–1703. [Published erratum appears in N Engl J Med 375:2010.]
34. National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 2014;370:2191–2200.
35. Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA; NHLBI ARDS Network. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2014;2: 611–620.
36. Bos LD, Schouten LR, van Vught LA, Wiewel MA, Ong DSY, Cremer O, et al.; MARS Consortium. Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis. Thorax 2017;72:876–883.
37. Kangelaris KN, Prakash A, Liu KD, Aouizerat B, Woodruff PG, Erle DJ, et al. Increased expression of neutrophil-related genes in patients with early sepsis-induced ARDS. Am J Physiol Lung Cell Mol Physiol 2015;308:L1102–L1113.
38. Dolinay T, Kim YS, Howrylak J, Hunninghake GM, An CH, Fredenburgh L, et al. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med 2012;185:1225–1234.
39. Wang Z, Beach D, Su L, Zhai R, Christiani DC. A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS. Am J Respir Cell Mol Biol 2008;38:724–732.
40. Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009;10:57–63.
41. Kovach MA, Stringer KA, Bunting R, Wu X, San Mateo L, Newstead MW, et al. Microarray analysis identifies IL-1 receptor type 2 as a novel candidate biomarker in patients with acute respiratory distress syndrome. Respir Res 2015;16:29.
42. Beliakova-Bethell N, Massanella M, White C, Lada S, Du P, Vaida F, et al. The effect of cell subset isolation method on gene expression in leukocytes. Cytometry A 2014;85:94–104.
43. Elkord E, Williams PE, Kynaston H, Rowbottom AW. Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells. Immunology 2005;114:204–212.
44. Fanning SL, George TC, Feng D, Feldman SB, Megjugorac NJ, Izaguirre AG, et al. Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-g production. J Immunol 2006;177:5829–5839.